CFLAR and renal carcinoma: To determine whether the anti-cancer effects of miR-708 in renal cancer cell lines were due to c-FLIPL inhibition or interaction with another gene, Caki cells were transiently transfected with a small interfering RNA (siRNA) specific to c-FLIPL (si-c-FLIPL) or a scrambled siRNA negative control (si-Cont).